|
|
|
Volumn 53, Issue 66, 1998, Pages
|
|
Antibiotic therapy and microbiologic considerations in the intensive care unit
a
|
|
Author keywords
Antimicrobials; Candida; Immunocompromized patients; Infection in ICU; Multiple resistant organisms; Nosocomial infection; Pathogens
|
|
Indexed keywords
AMIKACIN;
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
AMPHOTERICIN B;
AMPICILLIN;
ANTIBIOTIC AGENT;
ANTIFUNGAL AGENT;
AZTREONAM;
CEFOTAXIME;
CEFOTETAN;
CEFOXITIN;
CEFTRIAXONE;
CEPHALOSPORIN DERIVATIVE;
CLINDAMYCIN;
COTRIMOXAZOLE;
FLUCONAZOLE;
GENTAMICIN;
IMIPENEM;
METRONIDAZOLE;
MEZLOCILLIN;
PENICILLIN DERIVATIVE;
PIPERACILLIN;
PIPERACILLIN PLUS TAZOBACTAM;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
TEICOPLANIN;
VANCOMYCIN;
ANTIINFECTIVE AGENT;
ANTIBIOTIC THERAPY;
BACTERIAL INFECTION;
BACTERIUM IDENTIFICATION;
CONFERENCE PAPER;
CRITICAL ILLNESS;
DRUG CHOICE;
DRUG EFFICACY;
HUMAN;
MYCOSIS;
PRIORITY JOURNAL;
CROSS INFECTION;
INTENSIVE CARE;
INTENSIVE CARE UNIT;
MICROBIOLOGY;
MULTIDRUG RESISTANCE;
REVIEW;
ANTI-BACTERIAL AGENTS;
BACTERIAL INFECTIONS;
CROSS INFECTION;
DRUG RESISTANCE, MULTIPLE;
HUMANS;
INTENSIVE CARE;
INTENSIVE CARE UNITS;
MYCOSES;
|
|
EID: 0031924111
PISSN: 00986577
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (22)
|
